Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
06/2002
06/13/2002WO2002016361A3 Nitrogenous heterocyclic compounds
06/13/2002WO2002008222A3 HETEROARYL-β-ALANINE DERIVATIVES AS ALPHA 4 INTEGRIN INHIBITORS
06/13/2002WO2001096330A3 Thrombin receptor antagonists
06/13/2002WO2001079198B1 Pyrazoles for inhibiting protein kinase
06/13/2002WO2001072721A3 Synergistic methods and compositions for treating cancer
06/13/2002US20020072618 As organic semiconductors can be dissolved in common organic solvents and applied to the surface of a substrate using inexpensive, low-temperature solution-based processing such as spin-coating, dip-coating, drop-casting, etc.
06/13/2002US20020072616 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
06/13/2002US20020072614 For therapy of cardiovascular, cerebrovascular, respiratory and renal disorders
06/13/2002US20020072520 For use in therapy of hyperlipidemia and arteriosclerotic disorders
06/13/2002US20020072517 Substituted cyclic amine metalloprotease inhibitors
06/13/2002DE10061790A1 Flüssigkristalline Verbindungen Liquid-crystalline compounds
06/13/2002DE10059864A1 Substituierte Amino-furan-2-yl-essigsäure- und Amino-thien-2-yl-essigsäure-Derivate Substituted amino-furan-2-yl-acetic acid and amino-thien-2-yl-acetic acid derivatives
06/13/2002CA2436662A1 Abca-1 elevating compounds against coronary artery disease or atherosclerosis
06/13/2002CA2431166A1 Indazolyl-substituted pyrroline compounds as kinase inhibitors
06/13/2002CA2431005A1 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis
06/13/2002CA2430966A1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
06/13/2002CA2430951A1 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
06/12/2002EP1213288A1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors
06/12/2002EP1212319A2 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission
06/12/2002EP1212315A1 Novel chalcones
06/12/2002EP1212311A1 Chalcone coumarins
06/12/2002EP1212307A1 Unsaturated oxime ethers and the use thereof for control of harmful fungi and veterinary pests
06/12/2002EP1212303A2 Bicyclic androgen and progesterone receptor modulator compounds and methods
06/12/2002EP1212300A1 Azacycloalkanone serine protease inhibitors
06/12/2002EP1212299A1 Substituted piperidine compounds useful as modulators of chemokine receptor activity
06/12/2002EP1212269A1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds
06/12/2002EP1212059A1 Iron chelators and uses thereof
06/12/2002EP0984778B1 Neuropeptide-y ligands
06/12/2002EP0751939B1 Naphthylamides as central nervous system agents
06/12/2002EP0688212B1 C9 taxane derivatives and pharmaceutical compositions containing them
06/12/2002CN1353706A Integrin receptor ligands
06/12/2002CN1353703A tricyclic fused heterocycle compounds, process for preparing the same and use thereof
06/12/2002CN1353695A Heterocyclically substituted benzimidazoles, production and application thereof
06/11/2002US6403810 Thiophene derivatives
06/11/2002US6403794 Reacting a biguanidine with an alkoxycarbonyl, or a substituted triazine with ammonia or an alkylamine
06/11/2002US6403792 Sulfonyl isatin compounds and methods of blocking apoptosis therewith
06/11/2002US6403633 Useful antiangiogenic, antiarthritic, antiinflammatory, antirestenotic, antiinvasive, antimetastic, antiosteoporotic, antiretinopathic, contraceptive and tumoristatic treatment agents
06/11/2002US6403632 Cyclic amide derivative
06/11/2002US6403610 Quinolylpropylpiperidine derivatives, their preparation and the compositions which comprise them
06/11/2002US6403595 Anticoagulants
06/11/2002US6403587 Autoimmune diseases, acute and chronic inflammatory conditions, allergic conditions, infection associated with inflammation, viral, transplantation tissue rejection, atherosclerosis, restenosis, hiv infectivity, and
06/11/2002US6403577 Hexamethyleneiminyl tachykinin receptor antagonists
06/11/2002US6403573 Compounds of azetidine and pyrrolidin
06/06/2002WO2002044171A1 Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
06/06/2002WO2002044170A2 Benzothiophene derivative compounds, process of preparation and use thereof
06/06/2002WO2002044166A1 Substituted quinolines as antitumor agents
06/06/2002WO2002044165A1 Quinoline derivatives as nk-3 antagonists
06/06/2002WO2002044156A2 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
06/06/2002WO2002044154A1 Novel compounds
06/06/2002WO2002024665A8 Arylalkane-sulfonamides having endothelin-antagonist activity
06/06/2002WO2002012198A3 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
06/06/2002WO2001093841A3 Barbituric acid analogs as therapeutic agents
06/06/2002WO2001087849A3 Modulators of tnf- alpha signaling
06/06/2002WO2001068643A3 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
06/06/2002WO2001046147A8 A process for preparing 4-substituted piperidines
06/06/2002US20020068755 Antitumor agents.
06/06/2002US20020068742 Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
06/06/2002US20020068739 Cholesteryl acyl transferase (ACAT) inhibitors; treatment of hyperlipidaemia and atherosclerosis.
06/06/2002US20020068734 Nitrogen-containing heterocyclic compounds
06/06/2002US20020068681 Substituted thienyl(amino)-sulphonyl(thio)ureas as herbicides
06/06/2002CA2430280A1 Substituted amino-furan-2-yl-acetic acid and amino-thien-2-yl-acetic acid derivatives and their use in the treatment of migraine and pain
06/06/2002CA2429892A1 Benzothiophene derivative compounds, process of preparation and use thereof
06/05/2002EP1211257A2 Metal coordination compound, luminescence device and display apparatus
06/05/2002EP1211250A1 C10 taxane derivatives and pharmaceutical compositions
06/05/2002EP1211249A1 Novel thiazine or pyrazine derivatives
06/05/2002EP1211246A1 Pyrimidine derivatives and herbicides containing the same
06/05/2002EP1211244A2 4,5-substitued imidazolyl compounds for the treatment of inflammation
06/05/2002EP1210343A2 Benzoic acid derivatives and their use as ppar receptor agonists
06/05/2002EP1210335A1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments
06/05/2002EP1210333A2 Novel herbicides
06/05/2002EP1210329A2 Aminoalkoxy carbazoles and their use as 5-ht ligands
06/05/2002EP1210328A1 Fused pyrrolecarboxamides: a new class of gaba brain receptor ligands
06/05/2002EP0966430B1 Anti-inflammatory compounds
06/05/2002EP0891336B1 Substituted 1-methyl-3-benzyluracils
06/05/2002EP0888343B1 Pyrazole-4-yl-hetaroyl derivatives as herbicides
06/05/2002EP0721942B1 Tetracyclic compound
06/05/2002CN1352641A Isonipecotamides for the treatment of integrin mediated disorders
06/04/2002US6399778 Crystalline solvate
06/04/2002US6399774 Compounds having activity as inhibitors of cytochrome P450RAI
06/04/2002US6399771 Cyclic imines as pesticides
06/04/2002US6399656 Using a benzopyran-3-carboxamide compound
06/04/2002US6399653 Ring fused dihydropyrans, process for preparation and use thereof
06/04/2002US6399644 Anticoagulants
06/04/2002US6399641 For therapy and prophylaxis of psychosis, schizophrenia, alzheimer's disease, cognitive disorders and restricted brain function caused by bypass operations or transplants, poor blood supply to the brain, spinal cord injuries etc.
06/04/2002US6399616 4-(4-(2-(5-(1,2,4-triazol-1-ylmethyl)-1h-indol-3-yl)ethyl)-1 -piperazinyl)furo(3,2-c)pyridine; combined serotonin reuptake inhibitor and partial agonist of 5-ht receptors; reduced latency; depression
06/04/2002US6399606 3-(((2r)-2-(((2-fluorophenyl)amino)carbonylamino)-2-(methoxy carbonyl)ethylthio)methyl)-4-oxo-4-(3-pyridyl)butanoic acid; treatment of chemotherapy induced neuropathy
06/04/2002US6399602 Anticancer agents
06/04/2002US6399598 Diheterocyclic metalloprotease inhibitors
06/04/2002CA2248366C Quinoxalinediones
06/04/2002CA2060557C (quinolin-2-ylmethoxy) indoles as inhibitors of the biosynthesis of leukotrienes
06/04/2002CA2020667C 4-acyloxyquinoline derivatives and insecticidal or acaricidal compositions containing same
05/2002
05/30/2002WO2002043449A1 Luminescent element material and luminescent element comprising the same
05/30/2002WO2002042289A2 Process for preparing 3-aryl-benzo[b]thiophenes
05/30/2002WO2002042281A1 Substituted 5-aryl and 5-heteroaryl-2-(2-hydroxyphenyl)-2h-benzotriazole derivatives as uv absorbers
05/30/2002WO2002042277A1 Novel compounds for use as hiv protease inhibitors
05/30/2002WO2002042273A2 Acid derivatives useful as serine protease inhibitors
05/30/2002WO2002042272A2 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
05/30/2002WO2002042268A2 Ep4 receptor selective agonists in the treatment of osteoporosis
05/30/2002WO2002041889A2 Indolsulfonyl compounds useful in the treatment of cns disorders
05/30/2002WO2002041835A2 Estrogen receptor modulators